Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2002 May;93(5):523–531. doi: 10.1111/j.1349-7006.2002.tb01287.x

High Expression of Human Uroplakin Ia in Urinary Bladder Transitional Cell Carcinoma

Susumu Kageyama 1, Tatsuhiro Yoshiki 1,✉, Takahiro Isono 2, Tsutomu Tanaka 1, Choi Jang Kim 1, Takeshi Yuasa 1, Yusaku Okada 1
PMCID: PMC5927031  PMID: 12036448

Abstract

Uroplakins (UPs) Ia, Ib, II, and III are tissue‐specific and differentiation‐dependent transmem‐brane proteins of the urothelium. We assessed the usefulness of human UP Ia as a histological marker by examining its expression in urinary bladder transitional cell carcinoma (TCC). A polyclonal antibody against human UP Ia was raised using a synthesized polypeptide. We applied our antibody to various organ tissues, including urothelium, and observed no crossreactivity. Analysis by RT‐PCR of normal urothelium, TCC and other organ tissues indicated that the human UP Ia gene expression is highly specialized to urothelium, and is conserved in TCC. Using immunohistochemistry, we investigated the expression of UP Ia in TCC from patients who had undergone radical cystectomy and from autopsy cases. Positive staining (10% or more positive cancer cells) was noted in primary lesions from 61 of 63 (96.8%) cystectomy patients. Depending on pathological grade, high expression (50% or more positive cancer cells) was observed in 17 of 18 (94.4%) moderately‐ to well‐differentiated TCC and in 36 of 45 (80.0%) poorly differentiated TCC. With regard to tumor invasion, high expression was noted in 20 of 22 (90.9%) superficial and 33 of 41 (80.5%) muscle‐invasive TCC. Cause‐specific survival rates were 68.6% and 75.0% in high‐ and low‐expression patients, respectively (log‐rank test, P=0.855, mean follow‐up; 65.0 months). In metastases, positive reactions were observed in 13 of 18 (72.2%) lesions. UP Ia may represent a specific histological marker judging from the stable expression, although its value as a prognostic factor remains undetermined.

Keywords: Uroplakin Ia, Bladder cancer, Immunohistochemistry

Full Text

The Full Text of this article is available as a PDF (7.4 MB).

http://www.ncc.go.jp/jp/statistics/1999/index_i.html (The last date of access was November 1st 2001.) Cancer Statistics in Japan 1999. The Foundation for Promotion of Cancer Research.

REFERENCES

  • 1. ) Greenlee , R. T. , Murray , T. , Bolden , S. and Wingo , P. A.Cancer statistics, 2000 . CA Cancer J. Clin. , 50 , 7 – 33 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Murphy , W. M. , Beckwith , J. B. and Farrow , G. M.Tumor of the urinary bladder . In “ Atlas of Tumor Pathology. Tumors of the Kidney, Bladder, and Related Urinary Structures ,” ed. Rosai J. and Sobin L. H. , pp. 199 ( 1994. ). Armed Forces Institute of Pathology; , Washington , DC . [Google Scholar]
  • 3. ) Yu , J. , Manabe , M. , Wu , X.‐R. , Xu , C. , Surya , B. and Sun , T.‐T.Uroplakin I: a 27‐kD protein associated with the asymmetric unit membrane of mammalian urothelium . J. Cell Biol. , 111 , 1207 – 1216 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. ) Yuasa , T. , Yoshiki , T. , Tanaka , T. , Kim , C.‐J. , Isono , T. and Okada , Y.Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma . Jpn. J. Cancer Res. , 89 , 879 – 882 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Yuasa , T. , Yoshiki , T. , Isono , T. , Tanaka , T. , Hayashida , H. and Okada , Y.Expression of transitional cell‐specific genes, uroplakin Ia and uroplakin II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients . Int. J. Urol. , 6 , 286 – 292 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Lu , J.‐J. , Kakehi , Y. , Takahashi , T. , Wu , X.‐X. , Yuasa , T. , Yoshiki , T. , Okada , Y. , Terachi , T. and Ogawa , O.Detection of circulating cancer cells by reverse transcription‐polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer . Clin. Cancer Res. , 6 , 3166 – 3171 ( 2000. ). [PubMed] [Google Scholar]
  • 7. ) Moll , R. , Wu , X.‐R. , Lin , J.‐H. and Sun , T.‐T.Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas . Am. J. Pathol. , 147 , 1383 – 1397 ( 1995. ). [PMC free article] [PubMed] [Google Scholar]
  • 8. ) Kaufmann , O. , Volmerig , J. and Manfred , D.Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas . Am. J. Clin. Pathol. , 113 , 683 – 687 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Wu , R.‐L. , Osman , I. , Wu , X.‐R. , Lu , M.‐L. , Zhang , Z.‐F. , Liang , F.‐X. , Hamza , R. , Scher , H. , Cordon‐Cardo , C. and Sun , T.‐T.Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma; alternative pathways of bladder epithelial differentiation and tumor formation . Cancer Res. , 58 , 1291 – 1297 ( 1998. ). [PubMed] [Google Scholar]
  • 10. ) Ogawa , K. , Johansson , S. L. and Cohen , S. M.Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract . Am. J. Pathol. , 155 , 1047 – 1050 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. ) Kageyama , S. , Yoshiki , T. , Hamaguchi , A. , Konishi , T. , Okada , Y. , Park , K.‐I. and Tomoyoshi , T.Clinical analysis of bladder cancer patients treated by radical cystectomy . Acta Urol. Jpn. , 43 , 1 – 6 ( 1997. ) (in Japanese) . [PubMed] [Google Scholar]
  • 12. ) Hermanek P. and Sobin L. H. , ed. “ UICC‐International Union against Cancer TNM Classification of Malignant Tumours ,” 4th Ed. , pp. 135 ( 1987. ). Springer‐Verlag; , Heidelberg . [Google Scholar]
  • 13. ) Tanaka , T. , Yoshiki , T. , Arai , Y. , Higuchi , K. , Kageyama , S. , Ogawa , Y. , Isono , T. and Okada , Y.Expression of platelet‐derived endothelial cell growth factor/thymidine phosphorylase in human bladder cancer . Jpn. J. Cancer Res. , 90 , 1344 – 1350 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. ) Yu , J. , Lin , J.‐H. , Wu , X.‐R. and Sun , T.‐T.Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins . J. Cell Biol. , 125 , 171 – 182 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Wu , X.‐R. , Lin , J.‐H. , Walz , T. , Häner , M. , Yu , J. , Aebi , U. and Sun , T.‐T.Mammalian uroplakins. A group of highly conserved urothelial differentiation‐related membrane proteins . J. Biol. Chem. , 269 , 13716 – 13724 ( 1994. ). [PubMed] [Google Scholar]
  • 16. ) Adachi , W. , Okubo , K. and Kinoshita , S.Human uroplakin Ib in ocular surface epithelium . Invest. Ophthalmol. Vis. Sci. , 41 , 2900 – 2905 ( 2000. ). [PubMed] [Google Scholar]
  • 17. ) Schaefer , B. M. , Lorenz , C. , Back , W. , Moll , R. , Sun , T.‐T. , Schober , C. , Waag , K. L. and Kramer , M. D.Autologous transplantation of urothelium into demucosalized gastrointestinal segments: evidence for epithelialization and differentiation of in vitro expanded and transplanted urothelial cells . J. Urol. , 159 , 284 – 290 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Zhang , Z.‐T. , Pak , J. , Shapiro , E. , Sun , T.‐T. and Wu , X.‐R.Urothelium‐specific expression of an oncogene in transgenie mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma . Cancer Res. , 59 , 3512 – 3517 ( 1999. ). [PubMed] [Google Scholar]
  • 19. ) Gitlin , J. S. , Wu , X.‐R. , Sun , T.‐T. , Ritchey , M. L. and Shapiro , E.New concepts of histological changes in experimental augmentation cystoplasty: insights into the development of neoplastic transformation at the enterovesical and gastrovesical anastomosis . J. Urol. , 162 , 1096 – 1100 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Ogawa , K. , St John , M. , Luiza de Oliveira , M. , Arnold , L. , Shirai , T. , Sun , T.‐T. and Cohen , S. M.Comparison of uroplakin expression during urothelial carcinogenesis induced by N‐butyl‐N‐(4‐hydroxybutyl)nitrosamine in rats and mice . Toxicol. Pathol. , 27 , 645 – 651 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Malagolini , N. , Cavallone , D. , Wu , X.‐R. and Serafini‐Cessi , F.Terminal glycosylation of bovine uroplakin III, one of the major integral‐membrane glycoproteins of mammalian bladder . Biochim. Biophys. Acta , 1475 , 231 – 237 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Shapiro , E. , Huang , H.‐Y. and Wu , X.‐R.Uroplakin and androgen receptor expression in the human fetal genital tract: insights into the development of the vagina . J. Urol. , 164 , 1048 – 1051 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Wu , X.‐R. , Manabe , M. , Yu , J. and Sun , T.‐T.Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation . J. Biol. Chem. , 265 , 19170 – 19179 ( 1990. ). [PubMed] [Google Scholar]
  • 24. ) Lobban , E. D. , Smith , B. A. , Hall , G. D. , Harnden , P. , Roberts , P. , Selby , P. J. , Trejdosiewicz , L. K. and Southgate , J.Uroplakin gene expression by normal and neoplastic human urothelium . Am. J. Pathol. , 153 , 1957 – 1967 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. ) Konety , B. R. , Nguyen , T. S. , Dhir , R. , Day , R. S. , Becich , M. J. , Stadler , W. M. and Getzenberg , R. H.Detection of bladder cancer using a novel nuclear matrix protein, BLCA‐4 . Clin. Cancer Res. , 6 , 2618 – 2625 ( 2000. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES